Literature DB >> 34121043

Genetic variations in medical research in the past, at present and in the future.

Yoichiro Kamatani1, Yusuke Nakamura2.   

Abstract

As we look so different, our genomic sequences vary enormously. The differences in our genome, genetic variations, have played very significant roles in medical research and have contributed to improvement of medical managements in the last 2-3 decades. Genetic variations include germline variations, somatic mutations, and diversities in receptor genes of rearranged immune cells, T cells and B cells. Germline variants are in some cases causative of genetic diseases, are associated with the risk of various diseases, and also affect drug efficacies or adverse events. Some somatic mutations are causative of tumor development. Recent DNA sequencing technologies allow us to perform single-cell analysis or detailed repertoire analysis of B and T cells. It is critically important to investigate temporal changes in immune environment in various anatomical regions in the next one to two decades. In this review article, we would like to introduce the roles of genetic variations in medical fields in the past, at present and in the future.

Entities:  

Keywords:  biobank; genetic variations; genome wide association study (GWAS); immunogenomics; pharmacogenomics; reverse genetics

Mesh:

Year:  2021        PMID: 34121043      PMCID: PMC8403528          DOI: 10.2183/pjab.97.018

Source DB:  PubMed          Journal:  Proc Jpn Acad Ser B Phys Biol Sci        ISSN: 0386-2208            Impact factor:   3.493


  66 in total

1.  JSNP: a database of common gene variations in the Japanese population.

Authors:  Mika Hirakawa; Toshihiro Tanaka; Yoichi Hashimoto; Masako Kuroda; Toshihisa Takagi; Yusuke Nakamura
Journal:  Nucleic Acids Res       Date:  2002-01-01       Impact factor: 16.971

2.  Homozygosity mapping of a gene responsible for gelatinous drop-like corneal dystrophy to chromosome 1p.

Authors:  M Tsujikawa; H Kurahashi; T Tanaka; M Okada; S Yamamoto; N Maeda; H Watanabe; Y Inoue; A Kiridoshi; K Matsumoto; Y Ohashi; S Kinoshita; Y Shimomura; Y Nakamura; Y Tano
Journal:  Am J Hum Genet       Date:  1998-10       Impact factor: 11.025

3.  A polymorphic DNA marker genetically linked to Huntington's disease.

Authors:  J F Gusella; N S Wexler; P M Conneally; S L Naylor; M A Anderson; R E Tanzi; P C Watkins; K Ottina; M R Wallace; A Y Sakaguchi
Journal:  Nature       Date:  1983 Nov 17-23       Impact factor: 49.962

4.  Genetic alterations during colorectal-tumor development.

Authors:  B Vogelstein; E R Fearon; S R Hamilton; S E Kern; A C Preisinger; M Leppert; Y Nakamura; R White; A M Smits; J L Bos
Journal:  N Engl J Med       Date:  1988-09-01       Impact factor: 91.245

5.  Gene for von Recklinghausen neurofibromatosis is in the pericentromeric region of chromosome 17.

Authors:  D Barker; E Wright; K Nguyen; L Cannon; P Fain; D Goldgar; D T Bishop; J Carey; B Baty; J Kivlin
Journal:  Science       Date:  1987-05-29       Impact factor: 47.728

6.  Localization of a gene for Fukuyama type congenital muscular dystrophy to chromosome 9q31-33.

Authors:  T Toda; M Segawa; Y Nomura; I Nonaka; K Masuda; T Ishihara; M Sakai; I Tomita; Y Origuchi; M ] Suzuki M [corrected to Sakai
Journal:  Nat Genet       Date:  1993-11       Impact factor: 38.330

7.  Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children.

Authors:  E S Lander; D Botstein
Journal:  Science       Date:  1987-06-19       Impact factor: 47.728

8.  HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.

Authors:  Soranun Chantarangsu; Taisei Mushiroda; Surakameth Mahasirimongkol; Sasisopin Kiertiburanakul; Somnuek Sungkanuparph; Weerawat Manosuthi; Woraphot Tantisiriwat; Angkana Charoenyingwattana; Thanyachai Sura; Wasun Chantratita; Yusuke Nakamura
Journal:  Pharmacogenet Genomics       Date:  2009-02       Impact factor: 2.089

9.  Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients.

Authors:  P Y Yew; H Alachkar; R Yamaguchi; K Kiyotani; H Fang; K L Yap; H T Liu; A Wickrema; A Artz; K van Besien; S Imoto; S Miyano; M R Bishop; W Stock; Y Nakamura
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

10.  Intratumoral expression levels of PD-L1, GZMA, and HLA-A along with oligoclonal T cell expansion associate with response to nivolumab in metastatic melanoma.

Authors:  Hiroyuki Inoue; Jae-Hyun Park; Kazuma Kiyotani; Makda Zewde; Azusa Miyashita; Masatoshi Jinnin; Yukiko Kiniwa; Ryuhei Okuyama; Ryota Tanaka; Yasuhiro Fujisawa; Hiroshi Kato; Akimichi Morita; Jun Asai; Norito Katoh; Kenji Yokota; Masashi Akiyama; Hironobu Ihn; Satoshi Fukushima; Yusuke Nakamura
Journal:  Oncoimmunology       Date:  2016-06-30       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.